<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28832514</article-id><article-id pub-id-type="pmc">5622679</article-id><article-id pub-id-type="doi">10.3390/nu9090919</article-id><article-id pub-id-type="publisher-id">nutrients-09-00919</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Avocado Consumption Increases Macular Pigment Density in Older Adults: A
Randomized, Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Scott</surname><given-names>Tammy M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rasmussen</surname><given-names>Helen M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Oliver</given-names></name></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Elizabeth J.</given-names></name><xref rid="c1-nutrients-09-00919" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-09-00919">Jean Mayer USDA Human Nutrition Research Center on Aging,
Tufts University, Boston, MA 02111, USA; <email>tammy.scott@tufts.edu</email> (T.M.S.);
<email>helen.rasmussen@tufts.edu</email> (H.M.R.); <email>oliver.chen@tufts.edu</email>
(O.C.)</aff><author-notes><corresp id="c1-nutrients-09-00919"><label>*</label>Correspondence:
<email>elizabeth.johnson@tufts.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2017</year></pub-date><volume>9</volume><issue>9</issue><elocation-id>919</elocation-id><history><date date-type="received"><day>09</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution (CC BY)
license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Lutein is selectively incorporated into the macula and brain. Lutein levels in the macula
(macular pigment; MP) and the brain are related to better cognition. MP density (MPD) is a
biomarker of brain lutein. Avocados are a bioavailable source of lutein. This study tests
the effects of the intake of avocado on cognition. This was a six-month, randomized,
controlled trial. Healthy subjects consumed one avocado (<italic>n</italic> = 20, 0.5
mg/day lutein, AV) vs. one potato or one cup of chickpeas (<italic>n</italic> = 20, 0
mg/day lutein, C). Serum lutein, MPD, and cognition were assessed at zero, three, and six
months. Primary analyses were conducted according to intent-to-treat principles, with
repeated-measures analysis. At six months, AV increased serum lutein levels by 25% from
baseline (<italic>p</italic> = 0.001). C increased by 15% (<italic>p</italic> = 0.030). At
six months, there was an increase in MPD from baseline in AV (<italic>p</italic> = 0.001)
and no increase in C. For both groups, there was an improvement in memory and spatial
working memory (<italic>p</italic> = 0.001; <italic>p</italic> = 0.032, respectively). For
AV only there was improved sustained attention (<italic>p</italic> = 0.033), and the MPD
increase was related to improved working memory and efficiency in approaching a problem
(<italic>p</italic> = 0.036). Dietary recommendations including avocados may be an
effective strategy for cognitive health.</p></abstract><kwd-group><kwd>lutein</kwd><kwd>avocado</kwd><kwd>macular pigment</kwd><kwd>bioavailability</kwd><kwd>cognition</kwd><kwd>older adult</kwd></kwd-group></article-meta></front><body><sec id="sec1-nutrients-09-00919"><title>1. Introduction</title><p>Lutein and zeaxanthin are dietary carotenoids that cross the blood brain barrier and
exclusively accumulate in the macular region of the retina. In the macula, lutein and
zeaxanthin are referred to as macular pigment (MP) [<xref rid="B1-nutrients-09-00919" ref-type="bibr">1</xref>]. MP is believed to have a role in visual function
and health by acting as a blue light filter and also possibly as an antioxidant and
anti-inflammatory agent [<xref rid="B2-nutrients-09-00919" ref-type="bibr">2</xref>]. Lutein
is transported in the circulation primarily on high density lipoproteins (HDL) [<xref rid="B3-nutrients-09-00919" ref-type="bibr">3</xref>], and HDL levels have been reported
to be significantly related to MP optical density (MPD) [<xref rid="B4-nutrients-09-00919" ref-type="bibr">4</xref>]. HDL has been reported to be a specific transporter
of lutein into neural tissue [<xref rid="B5-nutrients-09-00919" ref-type="bibr">5</xref>].
Thus increasing the dietary intake of lutein, as well as altering the lipoprotein profile,
may impact MPD.</p><p>MPD has been reported to be significantly related to cognitive function in both young and
older adults [<xref rid="B6-nutrients-09-00919" ref-type="bibr">6</xref>,<xref rid="B7-nutrients-09-00919" ref-type="bibr">7</xref>,<xref rid="B8-nutrients-09-00919" ref-type="bibr">8</xref>]. Studies in nonhuman primates and humans show that
retinal lutein is significantly associated with lutein brain concentrations [<xref rid="B9-nutrients-09-00919" ref-type="bibr">9</xref>,<xref rid="B10-nutrients-09-00919" ref-type="bibr">10</xref>]. Thus MPD is a non-invasive biomarker for brain
concentrations of lutein. Lutein concentrations in the older adult brain are positively
associated with a variety of pre-mortem cognitive measures [<xref rid="B11-nutrients-09-00919" ref-type="bibr">11</xref>]. Furthermore, lutein supplementation significantly
improves verbal fluency scores in healthy older adults [<xref rid="B12-nutrients-09-00919" ref-type="bibr">12</xref>]. The effect of lutein-containing foods on
cognitive function is not known. Lutein containing foods include green leafy vegetables,
squash, broccoli, and eggs [<xref rid="B13-nutrients-09-00919" ref-type="bibr">13</xref>].
Avocados are a particularly bioavailable source [<xref rid="B14-nutrients-09-00919" ref-type="bibr">14</xref>]. An avocado-enriched diet improves lipoprotein
profiles, with increases in HDL and decreases in low-density lipoproteins (LDL) [<xref rid="B15-nutrients-09-00919" ref-type="bibr">15</xref>,<xref rid="B16-nutrients-09-00919" ref-type="bibr">16</xref>]. Based on the sum of these findings, the primary
objective of this study was to test the effects of the intake of avocado versus potatoes or
chickpeas on cognition in older adults. A secondary objective was to investigate the effect
of avocado consumption on anti-oxidation, anti-inflammation, and the lipoprotein
profile.</p></sec><sec id="sec2-nutrients-09-00919"><title>2. Materials and Methods</title><sec id="sec2dot1-nutrients-09-00919"><title>2.1. Subjects</title><p>Forty-eight healthy, non-smoking women and men were recruited from the general population
from January 2013 through January 2014. All subjects completed the study by July 2014. The
subjects underwent a screening examination that included a medical history, physical
examination, and a routine blood clinical chemistry profile. The inclusion criteria
included low intakes of lutein-rich foods (less than three servings/week of green leafy
vegetables, broccoli, eggs). The exclusion criteria included any history of liver, kidney
or pancreatic disease; anemia; active bowel disease or resection; bleeding disorders; and
avocado, potato or chickpea allergies. Moreover, individuals taking medications
interfering with fat absorption (e.g., bile acid sequestrants, exetimibe) were excluded.
Other exclusion criteria included the current use of steroids, or antipsychotic,
antimanic, anti-inflammatory, monoamine inhibitors, or dementia medications. Additionally,
the use of any nutrient supplement for the previous two months was grounds for exclusion.
Aspirin and non steroidal anti-inflammatory drugs were not considered as grounds for
exclusion.</p></sec><sec id="sec2dot2-nutrients-09-00919"><title>2.2. Experimental Design</title><p>The study was designed as a randomized, controlled trial. The study protocol was approved
by the Human Investigative Review Committee of Tufts University. Informed consent was
obtained from all subjects. This study was registered at ClinicalTrials.gov
(<uri xlink:href="https://clinicaltrials.gov/ct2/show/NCT01620567?term=avocado&#x00026;rank=4">https://clinicaltrials.gov/ct2/show/NCT01620567?term=avocado&#x00026;rank=4</uri>;
Clinical Trial Registry number: NCT01621646).</p></sec><sec id="sec2dot3-nutrients-09-00919"><title>2.3. Study Protocol</title><p>Upon enrollment, the research dietitian (HMR) randomized subjects to either group using a
randomization plan generator (<uri xlink:href="http://www.randomization.com/">http://www.randomization.com/</uri>). The randomization
assignment was known to the Metabolic Kitchen Laboratory staff only. At baseline and
Months three and six, the subjects visited the Jean Mayer U.S. Department of Agriculture
Human Nutrition Center on Aging at Tufts University and provided a fasting blood sample.
Serum were separated from red blood cells (800 g, 10 min) and were stored at &#x02212;70
&#x000b0;C until analyzed. Measures of cognitive function and MPD were performed at these
visits. A food frequency questionnaire was also given [<xref rid="B17-nutrients-09-00919" ref-type="bibr">17</xref>] and analyzed by the research dietitian. Dietary
intake data were analyzed using Nutrition Data System for Research software (version 2016,
University of Minnesota, Minneapolis, MN, USA), developed by the Nutrition Coordinating
Center (NCC), University of Minnesota, Minneapolis, MN, USA. The subjects were instructed
to not change their dietary habits throughout the study period.</p><p>The subjects visited the Nutrition Center monthly to pick up supplies of fresh avocados
(Hass Avocado&#x02122;, Mission Viejo, CA, USA, approximately 135 g/day of avocado
containing 0.5 mg lutein, 13 g/day monounsaturated fats) or potatoes (Costa
Produce&#x02122;, Boston, MA, USA)/chickpeas (Progresso&#x02122;, Minneapolis, MN, USA)
(containing no lutein, &#x0003c;1 g/day monounsaturated fats). The lutein content of the
avocados was measured by our laboratory using previously published methods [<xref rid="B18-nutrients-09-00919" ref-type="bibr">18</xref>] and was found to be 0.40 &#x000b1;
0.01 mg/100 g (edible portion). The monounsaturated fat content of avocados is 9.8 g/100 g
[<xref rid="B19-nutrients-09-00919" ref-type="bibr">19</xref>]. Foods in each group were
selected to be isocaloric. The subjects had the option to have avocados shipped weekly
directly to their homes. The subjects were also offered pre-made foods containing
avocados, potatoes, or chickpeas (soup, pesto, sauce, dip, ice cream) for easy
incorporation into their daily meals. However, only a small proportion of the foods
(&#x0003c;10%) were consumed in these forms. The subjects were instructed to consume one
avocado/day (treatment group) or one potato or one cup of chickpeas (control group) or the
equivalent contained in pre-made foods. The total amount of lutein provided by the
avocados over the study period was 90 mg. At the monthly visits, compliance was monitored
by an interview conducted by a dietitian with specific questions on the subject&#x02019;s
daily intake of the intervention foods and a review of compliance calendars. The
maintenance of dietary habits was also determined at these times. Semi-monthly telephone
monitoring occurred to check on subjects&#x02019; food supplies and to query them about any
situation that may have occurred with food products. The subjects were encouraged to
contact the kitchen laboratory or the dietitian if there was any question about the
quality or amount of food supplies they received.</p></sec><sec id="sec2dot4-nutrients-09-00919"><title>2.4. Serum Analysis for Carotenoids and Biomarkers of Oxidative Stress and
Inflammation</title><p>Serum lutein was extracted and analyzed by high performance liquid chromatography by
using a method previously described [<xref rid="B20-nutrients-09-00919" ref-type="bibr">20</xref>]. The oxidative status was measured using low density lipoprotein (LDL)
resistance against oxidation [<xref rid="B21-nutrients-09-00919" ref-type="bibr">21</xref>]. &#x003b2;-Amyloid and C-reactive protein were measured in serum as markers of
inflammation using a direct solid-phase enzyme immunoassay (Innogenetics N.V., Ghent,
Belgium) and a chemiluminescent assay (Diagnostic Products Corporation, Los Angeles, CA,
USA), respectively.</p></sec><sec id="sec2dot5-nutrients-09-00919"><title>2.5. Lipoprotein Analysis</title><p>Protocol was as specified in a Beckman Coulter AU400 standard operating procedure insert
for total cholesterol, HDL, LDL, and triglycerides. (Beckman Coulter Inc., Brea, CA,
USA).</p></sec><sec id="sec2dot6-nutrients-09-00919"><title>2.6. Measurement of Macular Pigment Density</title><p>A psychophysical measurement of MPD, using heterochromatic flicker photometry, was used
as a measure of lutein and zeaxanthin in neural tissue [<xref rid="B22-nutrients-09-00919" ref-type="bibr">22</xref>]. The measurements were conducted using a
modified macular densitometer (Macular Metrics Corp, Rehoboth, MA, USA), which was
simplified in its construction from the original densitometer described earlier [<xref rid="B23-nutrients-09-00919" ref-type="bibr">23</xref>] and modified for clinical use.
MPD at 0.5&#x000b0; eccentricity and at two wavelengths (460 and 500 nm) was assessed. The
standardized protocol for measuring MPD by heterochromatic flicker photometry has been
shown to be reliable and safe in older adults [<xref rid="B24-nutrients-09-00919" ref-type="bibr">24</xref>].</p></sec><sec id="sec2dot7-nutrients-09-00919"><title>2.7. Cognitive Tests</title><p>The subjects underwent cognitive testing using a computerized battery of cognitive tests
designed to evaluate several cognitive domains, including memory, processing speed, and
attention [<xref rid="B25-nutrients-09-00919" ref-type="bibr">25</xref>] (<xref ref-type="table" rid="nutrients-09-00919-t001">Table 1</xref>, CANTAB, Cambridge
Cognition Ltd., Cambridge, UK). These tests required a finger-operated subject response on
a touch-screen tablet personal computer. A set of scripted instructions was provided for
each test.</p></sec><sec id="sec2dot8-nutrients-09-00919"><title>2.8. Sample Size Calculation</title><p>Standard sample size calculation procedures estimate that 20/group gives an 80% chance
that a 0.05 level test of significance will find a significant difference in MPD. This is
based on the study by Wenzel et al., who reported a significant increase of 0.09 OD in MPD
with one egg/day (containing lutein/zeaxanthin at 0.33 mg/day) for 12 weeks [<xref rid="B26-nutrients-09-00919" ref-type="bibr">26</xref>].</p></sec><sec id="sec2dot9-nutrients-09-00919"><title>2.9. Statistical Analyses</title><p>The treatment groups were compared for possible differences in characteristics and
outcome measures at baseline using independent samples, <italic>t</italic>-Test, or
Chi-Square where appropriate. The primary analyses were conducted according to
intent-to-treat principles. A repeated-measures analysis was utilized, with the dependent
variable being changed to the follow-up time points. The independent variables were
treatment, time (visit), and the treatment &#x000d7; time interaction. Type I error was
controlled using a gatekeeping strategy; a hierarchical structure was identified as the
treatment &#x000d7; time interaction, followed by the main effects, followed by specific
within- and between- group comparisons. Pearson correlations were conducted to evaluate
the relationships between measures. Comparisons were performed only at &#x003b1; = 0.05 if
significance was obtained at &#x003b1; = 0.05 at the higher level in the hierarchy. The data
are presented as mean &#x000b1; SD. All significance testing was two-tailed using an alpha of
0.05. The data were analyzed with SPSS (version 22, Armonk, New York, NY, USA).</p></sec></sec><sec id="sec3-nutrients-09-00919"><title>3. Results</title><sec id="sec3dot1-nutrients-09-00919"><title>3.1. Subject Characteristics</title><p>Forty subjects completed the study (83% of enrolled). Eight subjects (five avocado, three
control) dropped out of the study for the following reasons: Aversion to the study
protocol (<italic>n</italic> = 2), diagnosis of colitis (<italic>n</italic> = 1), did not
follow study directions (<italic>n</italic> = 2), and did not show for study visit and
could not be reached (<italic>n</italic> = 3). No adverse events were reported.</p><p>There were no significant differences between the two groups in baseline measures of age,
body mass index (kg/m<sup>2</sup>), education, lutein/zeaxanthin, monounsaturated fat
intake, (<xref ref-type="table" rid="nutrients-09-00919-t002">Table 2</xref>), serum
concentrations of lutein and zeaxanthin, C-reactive protein, &#x003b2;-amyloid, blood
lipids, LDL oxidation, or MPD (<xref ref-type="table" rid="nutrients-09-00919-t003">Table
3</xref>). </p><p>Among the cognitive measures, there were also no significant differences in baseline
measures of cognitive function with the exception of a delayed matching sample, a measure
of short term visual memory for which the avocado group had a higher (better) measure.
(<xref ref-type="table" rid="nutrients-09-00919-t004">Table 4</xref>).</p><p>Compliance with consumption of the food interventions (days consumed/total days of study)
as assessed by an interview with a dietitian compliance calendars was 98% and 99% for the
avocado group and control group, respectively. There was no significant change in dietary
habits or body weight for either group throughout the study.</p></sec><sec id="sec3dot2-nutrients-09-00919"><title>3.2. Serum Analysis for Carotenoids and Biomarkers of Oxidative Stress and
Inflammation</title><p>There was no treatment by time interaction or main effect of treatment for either lutein
or zeaxanthin. There was a main effect for time for serum lutein and zeaxanthin. In
post-hoc analyses of the avocado group, there was a significant increase in serum lutein
concentrations from baseline at both three and six months, with increases that were
&#x0003e;25% for both time points. There were no changes in serum zeaxanthin throughout the
study period in the avocado group (<xref ref-type="table" rid="nutrients-09-00919-t003">Table 3</xref>). In the control group, there was a 15% increase in serum lutein at six
months that was significantly greater than baseline (<xref ref-type="table" rid="nutrients-09-00919-t003">Table 3</xref>). Serum zeaxanthin concentrations in the
control group were significantly increased from baseline by &#x0003e;20% at both time
points.</p><p>There were no changes in measures of oxidative stress and inflammation throughout the
study in either group.</p></sec><sec id="sec3dot3-nutrients-09-00919"><title>3.3. Lipoproteins</title><p>There was no treatment by time interaction or main effect of treatment or time for HDL,
LDL, or total cholesterol (<xref ref-type="table" rid="nutrients-09-00919-t003">Table
3</xref>). There was a trend for a treatment by time interaction for triglycerides
(<italic>p</italic> = 0.061). At six months, there was a trend for the triglyercides to
decrease from baseline in the avocado group (<italic>p</italic> = 0.075) and increase in
the control group (<italic>p</italic> = 0.06). The change (six months baseline) in HDL was
correlated with the change in both serum lutein and zeaxanthin (<italic>r</italic> = 0.43
and 0.54; <italic>p</italic> = 0.058 and 0.014, respectively) in the avocado group only,
and the change in triglycerides was negatively correlated with the change in serum
zeaxanthin in the control group (<italic>r</italic> = &#x02212;0.41, <italic>p</italic> =
0.073).</p></sec><sec id="sec3dot4-nutrients-09-00919"><title>3.4. Macular Pigment Density</title><p>There was no treatment by time interaction or main effect of treatment for MPD. There was
a main effect of time. In post hoc analyses, MPD increased from baseline by more than 25%
at both three and six months in the avocado group (<xref ref-type="table" rid="nutrients-09-00919-t003">Table 3</xref>). These changes were not related to the
changes in serum concentrations of lutein or zeaxanthin. In the control group, MPD
significantly increased from baseline by approximately 17% in the control group at three
months (<xref ref-type="table" rid="nutrients-09-00919-t003">Table 3</xref>) and was
significantly related to the change in serum zeaxanthin (<italic>r</italic> = 0.607,
<italic>p</italic> = 0.005) but not to the change in serum lutein. The increase in MPD
or its relationship with serum zeaxanthin was not sustained at six months.</p></sec><sec id="sec3dot5-nutrients-09-00919"><title>3.5. Cognitive Measures</title><p>There was no treatment by time interaction or main effect for treatment for any of the
cognitive tests. There was a main effect for time for Spatial Working Memory, Rapid Visual
Information Processing, Stockings of Cambridge, and Paired Associate Learning Test (<xref ref-type="table" rid="nutrients-09-00919-t004">Table 4</xref>). For the Paired Associate
Learning test, Months 3 and 6 were significantly different than baseline for both groups
(<xref ref-type="table" rid="nutrients-09-00919-t004">Table 4</xref>). In the avocado
group, there was a significant improvement from baseline in the Spatial Working Memory
measure at three months, as well as in the Stockings of Cambridge test at six months
(<xref ref-type="table" rid="nutrients-09-00919-t004">Table 4</xref>). There were no
other significant changes in cognitive measures for the control group.</p></sec><sec id="sec3dot6-nutrients-09-00919"><title>3.6. Relationship between MPD and Cognitive Measures</title><p>In the avocado group, the change in MPD was significantly related to changes in Spatial
Working Memory (<italic>r</italic> = 0.46, <italic>p</italic> = 0.041) and the efficiency
in approaching a problem (<italic>r</italic> = 0.47, <italic>p</italic> = 0.036). There
were no relationships between the change in MPD and the change in cognition in the control
group.</p></sec></sec><sec id="sec4-nutrients-09-00919"><title>4. Discussion</title><p>A dietary intervention with avocados was found to improve cognitive function. This
improvement could be related to the increase in MPD, a biomarker of lutein contained in
brain tissue [<xref rid="B9-nutrients-09-00919" ref-type="bibr">9</xref>,<xref rid="B10-nutrients-09-00919" ref-type="bibr">10</xref>]. The proposed mechanisms by which
lutein benefits cognitive function in the elderly may involve its role as an antioxidant or
anti-inflammatory agent [<xref rid="B2-nutrients-09-00919" ref-type="bibr">2</xref>].
However, in this study, no changes in oxidative stress or inflammation biomarkers were
detected in either group. These measures were within a normal range at the start of the
study, and therefore an improved antioxidant for anti-inflammatory status would have been
difficult to detect. Other proposed mechanisms by which lutein is embedded in neural tissue
include the modulation of functional properties of synaptic membranes, along with certain
changes in the physiochemical and structural features of these membranes [<xref rid="B27-nutrients-09-00919" ref-type="bibr">27</xref>].</p><p>It is interesting to note that the control group had a significant increase in one of the
cognitive measures with time (PAL). We speculate that this may be attributed to a learning
effect, demonstrating the importance of including a control group in intervention trials.
Furthermore, it is probable that phytonutrients other than lutein in chickpeas and potatoes
may improve cognitive function.</p><p>Our study finds that avocados have a positive impact on lutein status, particularly in
neural tissue. This finding confirms what other investigators have reported [<xref rid="B14-nutrients-09-00919" ref-type="bibr">14</xref>]. The high bioavailability of
lutein contained in avocados has been previously reported [<xref rid="B14-nutrients-09-00919" ref-type="bibr">14</xref>]. Presumably adding oil, grinding, or cooking would
further increase this bioavailability. It was not possible to test this in our study, given
the low number of subjects who chose the option of prepared foods. Although the amount of
lutein contained in avocados is relatively small (0.5 mg/medium avocado), this dose was
extremely effective in increasing serum lutein. For comparison, we have reported that lutein
supplementation (12 mg/day for 4 months) increased serum lutein by 0.22 nmol/L per mg lutein
[<xref rid="B28-nutrients-09-00919" ref-type="bibr">28</xref>]. This present study finds
an increase in serum of 0.93 nmol/L per mg lutein contained in avocado. The control group
also had a small but significant increase in serum lutein at six months. This unexpected
result may have been due to unaccounted for dietary changes during the study, although this
was not indicated in the dietary interviews.</p><p>The daily consumption of avocados resulted in increases in serum lutein that were
significantly related to increases HDL, the major transporter of lutein in the circulation
[<xref rid="B3-nutrients-09-00919" ref-type="bibr">3</xref>]. Monounsaturated fatty acids
from avocados have been reported to increase HDL in mild hypercholesterolemic patients
[<xref rid="B16-nutrients-09-00919" ref-type="bibr">16</xref>]. Avocado consumption has
also been reported to lower LDL-cholesterol and triglycerides [<xref rid="B16-nutrients-09-00919" ref-type="bibr">16</xref>,<xref rid="B29-nutrients-09-00919" ref-type="bibr">29</xref>]. Although the changes in lipoproteins were small but trending towards
significance, simultaneous increases in serum lutein and HDL concentrations and decreases in
LDL and triglycerides are likely to be effective in increasing lutein in neural tissue
through an enrichment of lutein in HDL. Indeed, this research found that avocado consumption
was particularly effective in increasing MPD. Higher lutein status, particularly as measured
by MPD, is believed to be important for visual function and health [<xref rid="B2-nutrients-09-00919" ref-type="bibr">2</xref>]. We and others have reported on the significant
relationships between MPD and cognitive function [<xref rid="B6-nutrients-09-00919" ref-type="bibr">6</xref>,<xref rid="B7-nutrients-09-00919" ref-type="bibr">7</xref>,<xref rid="B8-nutrients-09-00919" ref-type="bibr">8</xref>]. This relationship
is likely due to MPD being a biomarker of lutein concentrations in brain tissue [<xref rid="B9-nutrients-09-00919" ref-type="bibr">9</xref>,<xref rid="B10-nutrients-09-00919" ref-type="bibr">10</xref>]. Among the carotenoids, lutein is preferentially
taken up into brain tissue, and lutein concentrations are the most consistently related to
cognitive function [<xref rid="B11-nutrients-09-00919" ref-type="bibr">11</xref>].</p><p>In our previous study of similar design and methods, we reported that a 12 mg/day lutein
(+0.5 mg/day zeaxanthin) supplement for four months in older adults significantly increased
MPD by 0.041 OD [<xref rid="B29-nutrients-09-00919" ref-type="bibr">29</xref>]. In this
present study, the consumption of 0.5 mg/day lutein contained in avocado for six months
significantly increased MP density by 0.101 OD. The total lutein/zeaxanthin doses given over
the study period were 1440 mg and 90 mg for the lutein supplement and avocado, respectively.
Thus, the avocado intervention increased MPD by more than double that of the supplement,
with only a small fraction of the amount of lutein. This suggests that other components in
avocado are particularly effective in the enrichment of neural lutein. The most likely
components are monounsaturated fatty acids.</p><p>Compared to the avocado group, the control group had smaller but significant increases in
MPD at three months. However, this was not sustained at the end of the study. This change
was not related to cognitive function. This is likely because the change was small and
transient.</p><p>One limitation to this study is the lack of a comparison of avocados with more commonly
consumed sources of lutein, e.g., green leafy vegetables. However, despite the relatively
smaller levels of lutein contained in avocados (0.4 mg/100 g), compared to spinach (13
mg/100 g), [<xref rid="B13-nutrients-09-00919" ref-type="bibr">13</xref>] significant
increases in lutein status resulted from the daily consumption of avocados. We speculate
that the lipid nature of avocados facilitates lutein bioavailability, similar to our report
on the higher bioavailability of lutein contained in egg compared to that contained in
spinach [<xref rid="B30-nutrients-09-00919" ref-type="bibr">30</xref>]. Another limitation
is whether it is realistic to consume one avocado a day. Avocados may be perceived as high
in fat. However, there were no significant weight gains in our study. This may be due to the
satiety effect of avocados [<xref rid="B31-nutrients-09-00919" ref-type="bibr">31</xref>].
In our study, avocados were consumed fresh or incorporated into foods that could be eaten as
a part of a meal (soup, pesto, sauce, dip, ice cream). This likely aided the high compliance
and weight maintenance and illustrates that such dietary modification can be practical.
However, the Dietary Guidelines recommend choosing a variety of fruits and vegetables [<xref rid="B32-nutrients-09-00919" ref-type="bibr">32</xref>]. Therefore, investigations on the
effects of other lutein-rich foods on cognitive function are warranted.</p></sec><sec id="sec5-nutrients-09-00919"><title>5. Conclusions</title><p>This study is an example of how practical dietary choices can be of benefit to healthy
aging. A dietary intervention with avocados was particularly effective in increasing MPD
levels, a biomarker of brain lutein. Increases in MPD were related to better cognitive
performance. Therefore, avocados could be an effective dietary strategy for cognitive health
in the aging population.</p></sec></body><back><ack><title>Acknowledgments</title><p>Funding source: Hass Avocado Board and USDA 58-1950-0-014. Any opinions, findings,
conclusions, or recommendations expressed in this publication are those of the authors and
do not necessarily reflect the view of the United States Department of Agriculture.</p></ack><notes><title>Author Contributions</title><p>H.M.R. and E.J.J. conceived and designed the experiments; T.M.S., H.M.R. and E.J.J.
performed the experiments; T.M.S. and E.J.J. analyzed the data; E.J.J. and O.C. contributed
reagents/materials/analysis tools; T.M.S., H.M.R., O.C. and E.J.J. wrote the paper. </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>Funding for this study was provided by the Hass Avocado Board. The funder did not have a
role in the study design, interpretation, or manuscript preparation.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-09-00919"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bone</surname><given-names>R.A.</given-names></name><name><surname>Landrum</surname><given-names>J.T.</given-names></name><name><surname>Tarsis</surname><given-names>S.L.</given-names></name></person-group><article-title>Preliminary identification of the human macular pigment</article-title><source>Vis. Res.</source><year>1985</year><volume>25</volume><fpage>1531</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.1016/0042-6989(85)90123-3</pub-id><pub-id pub-id-type="pmid">3832576</pub-id></element-citation></ref><ref id="B2-nutrients-09-00919"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>E.J.</given-names></name></person-group><article-title>A role for lutein and zeaxanthin in visual and cognitive function
throughout the lifespan</article-title><source>Nutr. Rev.</source><year>2014</year><volume>72</volume><fpage>605</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1111/nure.12133</pub-id><pub-id pub-id-type="pmid">25109868</pub-id></element-citation></ref><ref id="B3-nutrients-09-00919"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Connor</surname><given-names>S.L.</given-names></name><name><surname>Johnson</surname><given-names>E.J.</given-names></name><name><surname>Klein</surname><given-names>M.L.</given-names></name><name><surname>Hughes</surname><given-names>S.</given-names></name><name><surname>Connor</surname><given-names>W.E.</given-names></name></person-group><article-title>Effect of dietary lutein and zeaxanthin on plasma carotenoids and their
transport in lipoproteins in age-related macular degeneration</article-title><source>Am. J. Clin. Nutr.</source><year>2007</year><volume>85</volume><fpage>762</fpage><lpage>769</lpage><pub-id pub-id-type="pmid">17344498</pub-id></element-citation></ref><ref id="B4-nutrients-09-00919"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renzi</surname><given-names>L.M.</given-names></name><name><surname>Hammond</surname><given-names>B.R.</given-names><suffix>Jr.</suffix></name><name><surname>Dengler</surname><given-names>M.</given-names></name><name><surname>Roberts</surname><given-names>R.</given-names></name></person-group><article-title>The relation between serum lipids and lutein and zeaxanthin in the serum
and retina: Results from cross-sectional, case-control and case study
designs</article-title><source>Lipids Health Dis.</source><year>2012</year><volume>11</volume><pub-id pub-id-type="doi">10.1186/1476-511X-11-33</pub-id><pub-id pub-id-type="pmid">22375926</pub-id></element-citation></ref><ref id="B5-nutrients-09-00919"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>W.E.</given-names></name><name><surname>Duell</surname><given-names>P.B.</given-names></name><name><surname>Kean</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>The prime role of HDL to transport lutein into the retina: Evidence from
HDL-deficient WHAM chicks having a mutant ABCA1 transporter</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2007</year><volume>48</volume><fpage>4226</fpage><lpage>4231</lpage><pub-id pub-id-type="doi">10.1167/iovs.06-1275</pub-id><pub-id pub-id-type="pmid">17724211</pub-id></element-citation></ref><ref id="B6-nutrients-09-00919"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishwanathan</surname><given-names>R.</given-names></name><name><surname>Iannaccone</surname><given-names>A.</given-names></name><name><surname>Scott</surname><given-names>T.M.</given-names></name><name><surname>Kritchevsky</surname><given-names>S.B.</given-names></name><name><surname>Jennings</surname><given-names>B.J.</given-names></name><name><surname>Carboni</surname><given-names>G.</given-names></name><name><surname>Forma</surname><given-names>G.</given-names></name><name><surname>Satterfield</surname><given-names>S.</given-names></name><name><surname>Harris</surname><given-names>T.</given-names></name><name><surname>Johnson</surname><given-names>K.C.</given-names></name><etal/></person-group><article-title>Macular pigment optical density is related to cognitive function in the
elderly</article-title><source>Age Aging</source><year>2013</year><volume>43</volume><fpage>271</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1093/ageing/aft210</pub-id><pub-id pub-id-type="pmid">24435852</pub-id></element-citation></ref><ref id="B7-nutrients-09-00919"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feeney</surname><given-names>J.</given-names></name><name><surname>Finucane</surname><given-names>C.</given-names></name><name><surname>Savva</surname><given-names>G.M.</given-names></name><name><surname>Cronin</surname><given-names>H.</given-names></name><name><surname>Beatty</surname><given-names>S.</given-names></name><name><surname>Nolan</surname><given-names>J.M.</given-names></name><name><surname>Kenny</surname><given-names>R.A.</given-names></name></person-group><article-title>Low macular pigment optical density is associated with lower cognitive
performance in a large, population-based sample of older adults</article-title><source>Neurobiol. Aging</source><year>2013</year><volume>34</volume><fpage>2449</fpage><lpage>2456</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.05.007</pub-id><pub-id pub-id-type="pmid">23769396</pub-id></element-citation></ref><ref id="B8-nutrients-09-00919"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renzi</surname><given-names>L.M.</given-names></name><name><surname>Dengler</surname><given-names>M.J.</given-names></name><name><surname>Puente</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>L.S.</given-names></name><name><surname>Hammond</surname><given-names>B.R.</given-names></name></person-group><article-title>Relationships between macular pigment optical density and cognitive
function in unimpaired and mildly cognitively impaired older adults</article-title><source>Neurobiol. Aging</source><year>2014</year><volume>35</volume><fpage>1695</fpage><lpage>1699</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.12.024</pub-id><pub-id pub-id-type="pmid">24508218</pub-id></element-citation></ref><ref id="B9-nutrients-09-00919"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishwanathan</surname><given-names>R.</given-names></name><name><surname>Neuringer</surname><given-names>M.</given-names></name><name><surname>Snodderly</surname><given-names>D.M.</given-names></name><name><surname>Schalch</surname><given-names>W.</given-names></name><name><surname>Johnson</surname><given-names>E.J.</given-names></name></person-group><article-title>Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in
primates</article-title><source>Nutr. Neurosci.</source><year>2013</year><volume>16</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1179/1476830512Y.0000000024</pub-id><pub-id pub-id-type="pmid">22780947</pub-id></element-citation></ref><ref id="B10-nutrients-09-00919"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishwanathan</surname><given-names>R.</given-names></name><name><surname>Schalch</surname><given-names>W.</given-names></name><name><surname>Johnson</surname><given-names>E.J.</given-names></name></person-group><article-title>Macular pigment carotenoids in the retina and occipital cortex are related
in humans</article-title><source>Nutr. Neurosci.</source><year>2016</year><volume>19</volume><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1179/1476830514Y.0000000141</pub-id><pub-id pub-id-type="pmid">25752849</pub-id></element-citation></ref><ref id="B11-nutrients-09-00919"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>E.J.</given-names></name><name><surname>Vishwanathan</surname><given-names>R.</given-names></name><name><surname>Johnson</surname><given-names>M.A.</given-names></name><name><surname>Hausman</surname><given-names>D.B.</given-names></name><name><surname>Davey</surname><given-names>A.</given-names></name><name><surname>Scott</surname><given-names>T.M.</given-names></name><name><surname>Green</surname><given-names>R.C.</given-names></name><name><surname>Miller</surname><given-names>L.S.</given-names></name><name><surname>Gearing</surname><given-names>M.</given-names></name><name><surname>Woodard</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Relationship between serum and brain carotenoids, alpha-tocopherol, and
retinol concentrations and cognitive performance in the oldest old from the Georgia
Centenarian Study</article-title><source>J. Aging Res.</source><year>2013</year><pub-id pub-id-type="doi">10.1155/2013/951786</pub-id><pub-id pub-id-type="pmid">23840953</pub-id></element-citation></ref><ref id="B12-nutrients-09-00919"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>E.J.</given-names></name><name><surname>McDonald</surname><given-names>K.</given-names></name><name><surname>Caldarella</surname><given-names>S.M.</given-names></name><name><surname>Chung</surname><given-names>H.-Y.</given-names></name><name><surname>Troen</surname><given-names>A.M.</given-names></name><name><surname>Snodderly</surname><given-names>D.M.</given-names></name></person-group><article-title>Cognitive findings of an exploratory trial of docosahexaenoic acid and
lutein supplementation in older women</article-title><source>Nutr. Neurosci.</source><year>2008</year><volume>11</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1179/147683008X301450</pub-id><pub-id pub-id-type="pmid">18510807</pub-id></element-citation></ref><ref id="B13-nutrients-09-00919"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>A.</given-names></name><name><surname>Rasmussen</surname><given-names>H.</given-names></name><name><surname>Johnson</surname><given-names>E.J.</given-names></name></person-group><article-title>Xanthophyll (lutein, zeaxanthin) content in fruits, vegetables and corn and
egg products</article-title><source>J. Food Compos. Anal.</source><year>2009</year><volume>22</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.jfca.2008.07.006</pub-id></element-citation></ref><ref id="B14-nutrients-09-00919"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unlu</surname><given-names>N.Z.</given-names></name><name><surname>Bohn</surname><given-names>T.</given-names></name><name><surname>Clinton</surname><given-names>S.K.</given-names></name><name><surname>Schwartz</surname><given-names>S.J.</given-names></name></person-group><article-title>Carotenoid absorption from salad and salsa by humans is enhanced by the
addition of avocado or avocado oil</article-title><source>J. Nutr.</source><year>2005</year><volume>135</volume><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">15735074</pub-id></element-citation></ref><ref id="B15-nutrients-09-00919"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvizouri-Mu&#x000f1;oz</surname><given-names>M.</given-names></name><name><surname>Carranza-Madriga</surname><given-names>l.J.</given-names></name><name><surname>Herrera-Abarca</surname><given-names>J.E.</given-names></name><name><surname>Ch&#x000e1;vez-Carbajal</surname><given-names>F.</given-names></name><name><surname>Amezcua-Gastelum</surname><given-names>J.L.</given-names></name></person-group><article-title>Effects of avocado as a source of monounsaturated fatty acids on plasma
lipid levels</article-title><source>Arch. Med. Res.</source><year>1992</year><volume>23</volume><fpage>163</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">1308699</pub-id></element-citation></ref><ref id="B16-nutrients-09-00919"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez Ledesma</surname><given-names>R.</given-names></name><name><surname>Frati Munari</surname><given-names>A.C.</given-names></name><name><surname>Hern&#x000e1;ndez Dom&#x000ed;nguez</surname><given-names>B.C.</given-names></name><name><surname>Cervantes Montalvo</surname><given-names>S.</given-names></name><name><surname>Hern&#x000e1;ndez Luna</surname><given-names>M.H.</given-names></name><name><surname>Ju&#x000e1;rez</surname><given-names>C.</given-names></name><name><surname>Moran Lira</surname><given-names>C.</given-names></name></person-group><article-title>Monounsaturated fatty acid (avocado) rich diet for mild
hypercholesterolemia</article-title><source>Arch. Med. Res.</source><year>1996</year><volume>27</volume><fpage>519</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">8987188</pub-id></element-citation></ref><ref id="B17-nutrients-09-00919"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimm</surname><given-names>E.B.</given-names></name><name><surname>Giovannucci</surname><given-names>E.L.</given-names></name><name><surname>Stampfer</surname><given-names>M.J.</given-names></name><name><surname>Colditz</surname><given-names>G.A.</given-names></name><name><surname>Litin</surname><given-names>L.B.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name></person-group><article-title>Reproducibility and validity of an expanded self-administered
semiquantitative food frequency questionnaire among male health
professionals</article-title><source>Am. J. Epidemiol.</source><year>1992</year><volume>135</volume><fpage>1114</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a116211</pub-id><pub-id pub-id-type="pmid">1632423</pub-id></element-citation></ref><ref id="B18-nutrients-09-00919"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzhingi</surname><given-names>T.</given-names></name><name><surname>Yeum</surname><given-names>K.-J.</given-names></name><name><surname>Russell</surname><given-names>R.M.</given-names></name><name><surname>Johnson</surname><given-names>E.J.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>G.</given-names></name></person-group><article-title>Determination of carotenoids in yellow maize, the effects of saponification
and food preparations</article-title><source>Int. J. Vitam. Nutr. Res.</source><year>2008</year><volume>78</volume><fpage>112</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1024/0300-9831.78.3.112</pub-id><pub-id pub-id-type="pmid">19003733</pub-id></element-citation></ref><ref id="B19-nutrients-09-00919"><label>19.</label><element-citation publication-type="gov"><person-group person-group-type="author"><name><surname>Haytowitz</surname><given-names>D.</given-names></name><name><surname>Showell</surname><given-names>B.</given-names></name><name><surname>Pehrsson</surname><given-names>P.</given-names></name></person-group><article-title>USDA National Nutrient Database for Standard Reference, Release
25</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://ars.usda.gov/Services/docs.htm?docid=8964">http://ars.usda.gov/Services/docs.htm?docid=8964</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2014-09-09">(accessed on 9
September 2014)</date-in-citation></element-citation></ref><ref id="B20-nutrients-09-00919"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuringer</surname><given-names>M.</given-names></name><name><surname>Sandstrom</surname><given-names>M.M.</given-names></name><name><surname>Johnson</surname><given-names>E.J.</given-names></name><name><surname>Snodderly</surname><given-names>D.M.</given-names></name></person-group><article-title>Nutritional manipulation of primate retinas, I: Effects of lutein or
zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus
monkeys</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2004</year><volume>45</volume><fpage>3234</fpage><lpage>3243</lpage><pub-id pub-id-type="doi">10.1167/iovs.02-1243</pub-id><pub-id pub-id-type="pmid">15326146</pub-id></element-citation></ref><ref id="B21-nutrients-09-00919"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.-Y.</given-names></name><name><surname>Bakhiet</surname><given-names>R.M.</given-names></name><name><surname>Hart</surname><given-names>V.</given-names></name><name><surname>Holtzman</surname><given-names>G.</given-names></name></person-group><article-title>Isoflavones improve plasma homocysteine status and antioxidant defense
system in healthy young men at rest but do not ameliorate oxidative stress induced by
80% VO<sub>2</sub>pk exercise</article-title><source>Ann. Nutr. Metab.</source><year>2005</year><volume>49</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1159/000084175</pub-id><pub-id pub-id-type="pmid">15735366</pub-id></element-citation></ref><ref id="B22-nutrients-09-00919"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stringham</surname><given-names>J.M.</given-names></name><name><surname>Hammond</surname><given-names>B.R.</given-names></name><name><surname>Nolan</surname><given-names>J.M.</given-names></name><name><surname>Wooten</surname><given-names>B.R.</given-names></name><name><surname>Mammen</surname><given-names>A.</given-names></name><name><surname>Smollon</surname><given-names>W.</given-names></name><name><surname>Snodderly</surname><given-names>D.M.</given-names></name></person-group><article-title>The utility of using customized heterochromatic flicker photometry (cHFP)
to measure macular pigment in patients with age-related macular
degeneration</article-title><source>Exp. Eye Res.</source><year>2008</year><volume>87</volume><fpage>445</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2008.08.005</pub-id><pub-id pub-id-type="pmid">18778703</pub-id></element-citation></ref><ref id="B23-nutrients-09-00919"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wooten</surname><given-names>B.R.</given-names></name><name><surname>Hammond</surname><given-names>B.R.</given-names><suffix>Jr.</suffix></name><name><surname>Land</surname><given-names>R.I.</given-names></name><name><surname>Snodderly</surname><given-names>D.M.</given-names></name></person-group><article-title>A practical method for measuring macular pigment optical
density</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>1999</year><volume>40</volume><fpage>2481</fpage><lpage>2489</lpage><pub-id pub-id-type="pmid">10509640</pub-id></element-citation></ref><ref id="B24-nutrients-09-00919"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snodderly</surname><given-names>D.M.</given-names></name><name><surname>Mares</surname><given-names>J.A.</given-names></name><name><surname>Wooten</surname><given-names>B.R.</given-names></name><name><surname>Oxton</surname><given-names>L.</given-names></name><name><surname>Gruber</surname><given-names>M.</given-names></name><name><surname>Ficek</surname><given-names>T.</given-names></name><collab>CAREDS Macular Pigment Group</collab></person-group><article-title>Macular pigment measurement by heterochromatic flicker photometry in older
subjects: The carotenoids and age-related eye disease study</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2004</year><volume>45</volume><fpage>531</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1167/iovs.03-0762</pub-id><pub-id pub-id-type="pmid">14744895</pub-id></element-citation></ref><ref id="B25-nutrients-09-00919"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>T.W.</given-names></name><name><surname>James</surname><given-names>M.</given-names></name><name><surname>Owen</surname><given-names>A.M.</given-names></name><name><surname>Sahakian</surname><given-names>B.J.</given-names></name><name><surname>McInnes</surname><given-names>L.</given-names></name><name><surname>Rabbitt</surname><given-names>P.</given-names></name></person-group><article-title>Cambridge Neuropsychological Test Automated Battery (CANTAB): A factor
analytic study of a large sample of normal elderly volunteers</article-title><source>Dementia</source><year>1994</year><volume>5</volume><fpage>266</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1159/000106735</pub-id><pub-id pub-id-type="pmid">7951684</pub-id></element-citation></ref><ref id="B26-nutrients-09-00919"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>A.J.</given-names></name><name><surname>Gerweck</surname><given-names>C.</given-names></name><name><surname>Barbato</surname><given-names>D.</given-names></name><name><surname>Nicolosi</surname><given-names>R.J.</given-names></name><name><surname>Handelman</surname><given-names>G.J.</given-names></name><name><surname>Curran-Celentano</surname><given-names>J.</given-names></name></person-group><article-title>A 12-wk egg intervention increases serum zeaxanthin and macular pigment
optical density in women</article-title><source>J. Nutr.</source><year>2006</year><volume>136</volume><fpage>2568</fpage><lpage>2573</lpage><pub-id pub-id-type="pmid">16988128</pub-id></element-citation></ref><ref id="B27-nutrients-09-00919"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gruszecki</surname><given-names>W.I.</given-names></name></person-group><article-title>Carotenoid Orientation: Role in Membrane Atabilization</article-title><source>Carotenoids in Health and Disease</source><person-group person-group-type="editor"><name><surname>Krinsky</surname><given-names>N.</given-names></name><name><surname>Mayne</surname><given-names>S.T.</given-names></name><name><surname>Sies</surname><given-names>H.</given-names></name></person-group><publisher-name>Marcel Dekker</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2004</year><fpage>151</fpage><lpage>164</lpage></element-citation></ref><ref id="B28-nutrients-09-00919"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>E.J.</given-names></name><name><surname>Chung</surname><given-names>H.-Y.</given-names></name><name><surname>Caldarella</surname><given-names>S.M.</given-names></name><name><surname>Snodderly</surname><given-names>D.M.</given-names></name></person-group><article-title>The influence of supplemental lutein and docosahexaenoic acid on serum,
lipoproteins, and macular pigmentation</article-title><source>Am. J. Clin. Nutr.</source><year>2008</year><volume>87</volume><fpage>1521</fpage><lpage>1529</lpage><pub-id pub-id-type="pmid">18469279</pub-id></element-citation></ref><ref id="B29-nutrients-09-00919"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Bordi</surname><given-names>P.L.</given-names></name><name><surname>Fleming</surname><given-names>J.A.</given-names></name><name><surname>Hill</surname><given-names>A.M.</given-names></name><name><surname>Kris-Etherton</surname><given-names>P.M.</given-names></name></person-group><article-title>Effect of a moderate fat diet with and without avocados on lipoprotein
particle number, size and subclasses in overweight and obese adults: A randomized,
controlled trial</article-title><source>J. Am. Heart Assoc.</source><year>2015</year><volume>4</volume><pub-id pub-id-type="doi">10.1161/JAHA.114.001355</pub-id><pub-id pub-id-type="pmid">25567051</pub-id></element-citation></ref><ref id="B30-nutrients-09-00919"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>H.-Y.</given-names></name><name><surname>Rasmussen</surname><given-names>H.M.</given-names></name><name><surname>Johnson</surname><given-names>E.J.</given-names></name></person-group><article-title>Lutein bioavailability is higher from lutein-enriched eggs than from
supplements and spinach in men</article-title><source>J. Nutr.</source><year>2004</year><volume>134</volume><fpage>1887</fpage><lpage>1893</lpage><pub-id pub-id-type="pmid">15284371</pub-id></element-citation></ref><ref id="B31-nutrients-09-00919"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wien</surname><given-names>M.</given-names></name><name><surname>Haddad</surname><given-names>E.</given-names></name><name><surname>Oda</surname><given-names>K.</given-names></name><name><surname>Sabat&#x000e9;</surname><given-names>J.</given-names></name></person-group><article-title>A randomized 3 &#x000d7; 3 crossover study to evaluate the effect of Hass
avocado intake on post-ingestive satiety, glucose and insulin levels, and subsequent
energy intake in overweight adults</article-title><source>Nutr. J.</source><year>2013</year><volume>12</volume><fpage>155</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-12-155</pub-id><pub-id pub-id-type="pmid">24279738</pub-id></element-citation></ref><ref id="B32-nutrients-09-00919"><label>32.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>US Department of Health and Human Services</collab><collab>US Department of Agriculture</collab></person-group><article-title>Dietary Guidelines for Americans 2015&#x02013;2020 8th
Edition</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://health.gov/dietaryguidelines/2015/guidelines">http://health.gov/dietaryguidelines/2015/guidelines</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2016-07-19">(assessed on 19
July 2016)</date-in-citation></element-citation></ref></ref-list></back><floats-group><table-wrap id="nutrients-09-00919-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-00919-t001_Table 1</object-id><label>Table 1</label><caption><p>Cognitive Test Battery [<xref rid="B25-nutrients-09-00919" ref-type="bibr">25</xref>].</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cognitive Test</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Description</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome Measures</th></tr></thead><tbody><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Attention Tests</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Test</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Score</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Choice Reaction
Time (CRT)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Two-choice
reaction time test with two possible stimuli and two possible responses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean correct
latency (response speed)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rapid Visual
Information Processing (RVIP)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Test of sustained
attention</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A&#x02019;&#x02014;Signal detection measure of sensitivity to the target
B&#x0201d;&#x02014;Signal detection measure of the strength of trace required to
elicit a response</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Visual
Memory Tests</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Test</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Score</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Delayed Match to
Sample (DMS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Test of
simultaneous and delayed matching to sample</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Percent correct
(all delays)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paired Associates
Learning (PAL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Assesses visual
memory and new learning</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total errors
(adjusted) Stages completed</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Executive Function, Working Memory, and Planning Tests</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Test</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Score</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spatial Span
(SSP)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Assesses working
memory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Span length</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spatial Span
Reverse (SSP-R)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Assesses working
memory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Span length</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spatial Working
Memory (SWM)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tests ability to
retain spatial information and manipulate items in working memory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Between errors
strategy</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stockings of
Cambridge (SOC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Test of spatial
planning and spatial working memory </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Problems solved in
minimum moves; Mean total thinking time: four moves</td></tr></tbody></table></table-wrap><table-wrap id="nutrients-09-00919-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-00919-t002_Table 2</object-id><label>Table 2</label><caption><p>The baseline characteristics of healthy subjects consuming one medium avocado a day
(Avocado, <italic>n</italic> = 20) or one medium potato or one cup of chickpeas a day
(Control, <italic>n</italic> = 20) for six months.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Avocado</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age, years, mean (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">63.3 (11.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">62.5 (9.2)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>, mean (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.1 (3.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.2 (2.4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Education (%), some college or greater</td><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">75</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sex (female/male)</td><td align="center" valign="middle" rowspan="1" colspan="1">14/6</td><td align="center" valign="middle" rowspan="1" colspan="1">11/9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dietary lutein/zeaxanthin, mg/day, mean (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0 (3.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.8 (2.7)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dietary protein, g/day (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">75.3 (41.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">68.2 (44.0)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dietary fat, g/day (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">74.3 (35.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">66.2 (41.4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dietary carbohydrate, g/day (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">246.0 (130.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">228.3 (130.8)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dietary
monounsaturated fatty acids, g/day (SD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.4 (12.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.3 (11.5)</td></tr></tbody></table></table-wrap><table-wrap id="nutrients-09-00919-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-00919-t003_Table 3</object-id><label>Table 3</label><caption><p>Serum lutein, zeaxanthin, macular pigment density (MPD), blood lipids, markers of
inflamation, and oxidative stress in healthy adults (&#x0003e;50 years) consuming one medium
avocado a day (Avocado, <italic>n</italic> = 20) or one medium potato or one cup of
chickpeas a day (Control, <italic>n</italic> = 20) for six months. Mean (SD).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Avocado</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Control</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baseline</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 Months</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 Months</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baseline</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 Months</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 Months
<sup>a</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lutein (nmol/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">330 (139)</td><td align="center" valign="middle" rowspan="1" colspan="1">423 (111) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">414 (147) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">322 (134)</td><td align="center" valign="middle" rowspan="1" colspan="1">352 (153)</td><td align="center" valign="middle" rowspan="1" colspan="1">371 (168) <sup>c</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Zeaxanthin (nmol/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">63 (17)</td><td align="center" valign="middle" rowspan="1" colspan="1">69 (45)</td><td align="center" valign="middle" rowspan="1" colspan="1">57 (30)</td><td align="center" valign="middle" rowspan="1" colspan="1">65 (33)</td><td align="center" valign="middle" rowspan="1" colspan="1">83 (47) <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">78 (40) <sup>e</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Macular pigment denisty (MPD), OD</td><td align="center" valign="middle" rowspan="1" colspan="1">0.393 (0.142)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.484 (0.178) <sup>f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.494 (0.137) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.380 (0.173)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.445 (0.177) <sup>g</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.424 (0.149)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Serum cholesterol (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">219 (52)</td><td align="center" valign="middle" rowspan="1" colspan="1">224 (56)</td><td align="center" valign="middle" rowspan="1" colspan="1">209 (43)</td><td align="center" valign="middle" rowspan="1" colspan="1">200 (46)</td><td align="center" valign="middle" rowspan="1" colspan="1">209 (42)</td><td align="center" valign="middle" rowspan="1" colspan="1">205 (54)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">high density lipoproteins (HDL) (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">57 (21)</td><td align="center" valign="middle" rowspan="1" colspan="1">61 (23)</td><td align="center" valign="middle" rowspan="1" colspan="1">61 (22)</td><td align="center" valign="middle" rowspan="1" colspan="1">58 (16)</td><td align="center" valign="middle" rowspan="1" colspan="1">56 (14)</td><td align="center" valign="middle" rowspan="1" colspan="1">57 (18)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">low-density lipoproteins (LDL) (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">129 (43)</td><td align="center" valign="middle" rowspan="1" colspan="1">135 (37)</td><td align="center" valign="middle" rowspan="1" colspan="1">131 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">132 (37)</td><td align="center" valign="middle" rowspan="1" colspan="1">137 (37)</td><td align="center" valign="middle" rowspan="1" colspan="1">137 (45)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Triglycerides (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">86 (64)</td><td align="center" valign="middle" rowspan="1" colspan="1">99 (82)</td><td align="center" valign="middle" rowspan="1" colspan="1">79 (57)</td><td align="center" valign="middle" rowspan="1" colspan="1">84 (55)</td><td align="center" valign="middle" rowspan="1" colspan="1">94 (84)</td><td align="center" valign="middle" rowspan="1" colspan="1">93 (58)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C-reactive protein, mg/L</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0 (2.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0 (2.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.7 (1.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.3 (1.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3 (2.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6 (1.6)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-Amyloid, pg/mL</td><td align="center" valign="middle" rowspan="1" colspan="1">7.7 (2.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.9 (2.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.5 (2.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.6 (5.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.2 (5.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.7 (5.2)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LDL Oxidative
lagtime (min)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.2 (22.9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.2 (14.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89.1 (17.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84.5 (26.6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.2 (16.9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.0 (18.7)</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup>
<italic>n</italic> = 19 for blood measures due to loss of sample due to technical
error. For each group, significance from baseline (<italic>p</italic> value):
<sup>b</sup> 0.001; <sup>c</sup> 0.03; <sup>d</sup> 0.01; <sup>e</sup> 0.004;
<sup>f</sup> 0.005; <sup>g</sup> 0.04; OD: optical density; HDL: high density
lipoprotein; LDL: low density lipoprotein.</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-09-00919-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-09-00919-t004_Table 4</object-id><label>Table 4</label><caption><p>Cognitive scores in healthy adults (&#x0003e;50 years) at baseline (0 month) and after three
and six months of consuming one medium avocado a day (Avocado, <italic>n</italic> = 20)
or one medium potato or one cup of chickpeas a day (Control, <italic>n</italic> = 20)
for six months. Mean (SD).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Avocado</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Control</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baseline</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 Months</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 Months</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baseline</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 Months</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 Months</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">CRT <italic>mean latency msec</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">347.4 (55.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">355.0 (53.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">342.8 (56.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">356.0 (70.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">367.0 (76.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">359.1 (75.5)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RVIP <italic>signal detection</italic>
<sup>4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.86 (0.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.92 (0.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.93 (0.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.90 (0.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.92 (0.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.92 (0.05)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">DMS <italic>percent correct all
delays</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">84.7 (12.8) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">86.0 (10.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">84.7 (13.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">80.0 (9.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">85.3 (11.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">83.0 (12.1)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PAL <italic>total errors (adjusted)</italic>
<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">28.0 (17.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.5 (14.2) <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">19.5 (15.5) <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">27.3 (18.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.9 (17.0) <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">16.8 (14.9) <sup>e</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SS Forward <italic>highest span</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">5.8 (1.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.2 (1.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.8 (1.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.8 (1.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.1 (1.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.1 (1.5)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SS Reverse <italic>highest span</italic>
<sup>1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.3 (1.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.3 (1.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5 (1.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0 (1.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.6 (1.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.7 (2.0) <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SWM errors <sup>3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">52.5 (19.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">43.6 (19.8) <sup>f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">48.4 (17.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">50.7 (19.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">47.80 (17.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">42.1 (19.8)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SOC <italic>#
completed in minimum moves</italic>
<sup>5</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.8 (2.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.7 (2.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8
(2.2)<sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.0 (2.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.4 (2.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.0 (2.7)</td></tr></tbody></table><table-wrap-foot><fn><p>CRT: Choice Reaction Time; RVIP: Rapid Visual Information Processing (higher scores
are better); DMS: Delayed Matching to Sample; PAL: Paired Associates Learning; SS:
Spatial Span; SWM: Spatial Working Memory (higher scores are worse); SOC: Stockings of
Cambridge. <sup>1</sup> significant time effect, no group or time &#x000d7; group
interaction (<italic>p</italic> = 0.045, univariate and adjusted for age and
education) ; <sup>2</sup>univariate: significant time effect (<italic>p</italic> =
0.001); adjusted with no main effects or interactions (although Months 3 and 6 are
significantly different than baseline for both groups); <sup>3</sup> univariate:
significant time effect (<italic>p</italic> = 0.032); adjusted for significant time
effect, no group or time &#x000d7; group interactions; <sup>4</sup> univariate:
significant time effect (<italic>p</italic> &#x0003c; 0.033) for the avocado group, no
group or time &#x000d7; group interaction; adjusted for no main effects or interactions;
<sup>5</sup> univariate: significant time effect (<italic>p</italic> = 0.029) for
the avocado group, no group or time &#x000d7; group interaction; adjusted for no main
effects or interactions. <sup>a</sup> Significantly different than the control at
baseline (<italic>p</italic> = 0.045). For each group, signicantly different than
baseline (<italic>p</italic> value): <sup>b</sup> 0.028; <sup>c</sup> 0.002;
<sup>d</sup> 0.018; <sup>e</sup> 0.001; <sup>f</sup> 0.020; <sup>g</sup> 0.042.</p></fn></table-wrap-foot></table-wrap></floats-group></article>